Su-Feng Chen

1.0k citations

24 papers · 813 indexed · h-index 12

Co-authors: Yaoh‐Shiang Lin Shin Nieh Chia‐Lin Liu Yun‐Ching Chang Min-Zu Wu Shu‐Wen Jao Juan Carlos Izpisúa Belmonte Carolyn O’Connor
Topics: Cancer Cells and Metastasis (12 papers)Cancer-related Molecular Pathways (3 papers)Synthesis and Characterization of Heterocyclic Compounds (2 papers)
Cited by: Cancer Research Oncology Immunology
Journals: PLoS ONE Nature Cell Biology Cancer Research
Partner nations: Taiwan United States Spain

In The Last Decade

Su-Feng Chen

22 papers receiving 806 citations

Peers

Countries citing papers authored by Su-Feng Chen

Since Specialization

Citations

This map shows the geographic impact of Su-Feng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su-Feng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su-Feng Chen more than expected).

Fields of papers citing papers by Su-Feng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su-Feng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su-Feng Chen. The network helps show where Su-Feng Chen may publish in the future.

Co-authorship network of co-authors of Su-Feng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Su-Feng Chen. A scholar is included among the top collaborators of Su-Feng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su-Feng Chen. Su-Feng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral soft tissue diagnosis as a novel teledentistry framework for the post-pandemic era: A systematic review 2025 ·Journal of Dental Sciences ·(unknown),(unknown),Su-Feng Chen,(unknown),(unknown),(unknown),Chung‐Ming Liu	0
2	Application of an Integrated Single-Cell and Three-Dimensional Spheroid Culture Platform for Investigating Drug Resistance Heterogeneity and Epithelial–Mesenchymal Transition (EMT) in Lung Cancer Subclones 2025 ·International Journal of Molecular Sciences ·(unknown),(unknown),(unknown),Yu‐Chun Lin,Yi‐Ming Chang,(unknown),Su-Feng Chen	1
3	Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion 2024 ·Cells ·Yi‐Ming Chang,Wen‐Yen Huang,(unknown),Chia‐Ing Jan,Shin Nieh,Yaoh‐Shiang Lin,Su-Feng Chen,Yu‐Chun Lin	4
4	Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies 2024 ·Journal of Dental Sciences ·(unknown),Su-Feng Chen,Shih‐Chieh Liao,(unknown),Jianhong Yu	1
5	Effect of Various Airborne Particle Abrasion Conditions on Bonding between Polyether-Ether-Ketone (PEEK) and Dental Resin Cement 2023 ·Polymers ·(unknown),Tzu‐Yu Peng,(unknown),(unknown),Yuichi Mine,I‐Ta Lee,(unknown),Su-Feng Chen,(unknown)	11
6	Interleukin-33-Enhanced CXCR4 Signaling Circuit Mediated by Carcinoma-Associated Fibroblasts Promotes Invasiveness of Head and Neck Cancer 2021 ·Cancers ·Yu‐Chun Lin,Wen‐Yen Huang,(unknown),Yi‐Ming Chang,Su-Feng Chen,(unknown),(unknown),Shin Nieh	12
7	Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma 2018 ·PLoS ONE ·(unknown),(unknown),(unknown),(unknown),Wen‐Yen Huang,Yu‐Chun Lin,Shin Nieh,Yaoh‐Shiang Lin,Su-Feng Chen,Fu‐Huang Lin	13
8	miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS 2017 ·Nature Cell Biology ·Min-Zu Wu,Wei‐Chung Cheng,Su-Feng Chen,Shin Nieh,Carolyn O’Connor,Chia‐Lin Liu,Wen‐Wei Tsai,Cheng-Jang Wu,(unknown),Yaoh‐Shiang Lin,Kou‐Juey Wu,Li‐Fan Lu,Juan Carlos Izpisúa Belmonte	114
9	The Effect of Individual and Neighbourhood Socioeconomic Status on Diabetes Mellitus Survival in Working Age Patients in Taiwan 2017 ·PLoS ONE ·(unknown),Su-Feng Chen,Shin Nieh,Chia‐Lin Liu,Yaoh‐Shiang Lin,Ching‐Chih Lee,Fu‐Huang Lin	6
10	Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative 2016 ·Oncotarget ·(unknown),Chia‐Lin Liu,Yun‐Ching Chang,Shin Nieh,Yaoh‐Shiang Lin,Shu‐Wen Jao,Su-Feng Chen,Tsung‐Yun Liu	18
11	The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer 2016 ·Oncotarget ·Chia‐Lin Liu,Su-Feng Chen,Min-Zu Wu,Shu‐Wen Jao,Yaoh‐Shiang Lin,(unknown),(unknown),(unknown),(unknown),Shin Nieh	30
12	Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis 2015 ·Cancer Research ·Min-Zu Wu,Su-Feng Chen,Shin Nieh,Christopher Benner,Luo‐Ping Ger,Chia‐Ing Jan,Li Ma,Chien‐Hung Chen,Tomoaki Hishida,Hong‐Tai Chang,Yaoh‐Shiang Lin,Núria Montserrat,Pedro Gascón,Ignacio Sancho-Martinez,Juan Carlos Izpisúa Belmonte	106
13	N,N′-di-(m-methylphenyi)-3,6-dimethyl-1,4-dihydro-1,2,4,5-tetrazine-1,4-dicarboamide (ZGDHu-1) suppresses the proliferation of PANC-1 pancreatic cancer cells via apoptosis and G2/M cell cycle arrest 2015 ·Oncology Reports ·Su-Feng Chen,Jun Xia,(unknown),Jinlin Liu,Wan-Xiang Li,(unknown),Wei‐Xiao Hu,(unknown)	4
14	ZGDHu-1 induces G2/M phase arrest and apoptosis in Kasumi-1 cells 2015 ·Molecular Medicine Reports ·Jun Xia,Su-Feng Chen,(unknown),(unknown),Wei‐Xiao Hu,Yonglie Zhou	9
15	Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade 2013 ·PLoS ONE ·Su-Feng Chen,Yaoh‐Shiang Lin,Shu‐Wen Jao,Yun‐Ching Chang,Chia‐Lin Liu,Yu‐Ju Lin,Shin Nieh	31
16	Reappraisal of the anticancer efficacy of quercetin in oral cancer cells 2013 ·Journal of the Chinese Medical Association ·Su-Feng Chen,(unknown),(unknown),Chia‐Lin Liu,Yun‐Ching Chang,Yaoh‐Shiang Lin	55
17	Quercetin Suppresses Drug-Resistant Spheres via the p38 MAPK–Hsp27 Apoptotic Pathway in Oral Cancer Cells 2012 ·PLoS ONE ·Su-Feng Chen,Shin Nieh,Shu‐Wen Jao,Chia‐Lin Liu,(unknown),Yun‐Ching Chang,(unknown),Yaoh‐Shiang Lin	95
18	Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer 2012 ·Annals of Surgical Oncology ·Shu‐Wen Jao,Su-Feng Chen,Yaoh‐Shiang Lin,Yun‐Ching Chang,(unknown),Chang‐Chieh Wu,Jong‐Shiaw Jin,Shin Nieh	30
19	Nonadhesive Culture System as a Model of Rapid Sphere Formation with Cancer Stem Cell Properties 2012 ·PLoS ONE ·Su-Feng Chen,Yun‐Ching Chang,Shin Nieh,Chia‐Lin Liu,(unknown),Yaoh‐Shiang Lin	137
20	Optical low-coherence reflectometry with resolution beyond the Fourier transform limit 2005 ·Optics Communications ·Chih-Wei Lu,Meng‐Tsan Tsai,(unknown),Su-Feng Chen,Yean‐Woei Kiang,C. C. Yang	0

About Su-Feng Chen

Su-Feng Chen is a scholar working on General Dentistry, Oncology and Orthodontics, having authored 24 papers that have together received 813 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (12 papers), Cancer-related Molecular Pathways (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Cancer Research (208 citations), Oncology (259 citations) and Immunology (182 citations). Su-Feng Chen has collaborated with scholars based in Taiwan, United States and Spain. Frequent co-authors include Yaoh‐Shiang Lin, Shin Nieh, Chia‐Lin Liu, Yun‐Ching Chang, Min-Zu Wu, Shu‐Wen Jao, Juan Carlos Izpisúa Belmonte, Shu‐Wen Jao, Carolyn O’Connor and Wen‐Wei Tsai. Their work appears in journals such as PLoS ONE, Nature Cell Biology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact